We can also observe a significant hypolipidemic phenotype in the carriers of ANGPTL3 LOF mutations, suggesting that ANGPTL3 LOF mutations can be served as a target for hyperlipidemia. Here, ANGPTL3 is linked to hyperlipidemia.